Dr. Orly Noivirt-Brik
Co-Founder & Co-CEO
Former Head of Bioinformatics and a member of the Leadership Team of Monsanto-Israel. Prior to that, Dr. Noivirt-Brik established the Bioinformatics department at Rosetta Green and led its R&D activity. Dr. Noivirt-Brik holds a PhD and M.SC. in Computational Biology from the Weizmann Institute of Science, and a B.Sc. in Chemistry and Biology (Summa Cum Laude) from Tel Aviv University.
Dr. Efrat Lidor Nili
Co-Founder & Co-CEO
Former Senior Scientist and a member of the Innovation Team of Monsanto-Israel. Prior to this Dr. Lidor Nili was a Senior Bioinformatician at Rosetta Green. Dr. Lidor Nili holds an interdisciplinary PhD from the Weizmann Institute of Science in which she combined molecular biology techniques with computational tools, a M.Sc. in Life Science from the Weizmann Institute of Science and a B.Sc. in Chemistry and Biology (Summa Cum Laude) from Tel-Aviv University.
Zeev has more than 18 years of experience in healthcare corporate development and leadership, strategic planning and corporate finance. Until 2017, Zeev served as CEO of Intec Pharma (NASDAQ, TASE: NTEC), a late clinical-stage biopharmaceutical company, including leading a NASDAQ IPO in August 2015, raising $34 million. Formerly, Zeev served as Intec's Executive Vice President Commercial Operations. Prior to that, Zeev served as Head of Life Sciences Strategic Consulting with PWC Israel and Head of Life Sciences Strategic Consulting with Andersen Israel, leading numerous business development, corporate development, strategic planning and corporate finance consulting projects with various life sciences companies.
Zeev is a Certified Public Accountant and has a BSc in Biology, a B.A. in accounting and has completed MSc studies in neuro-biochemistry, each from Tel Aviv University.
Managing Partner at CE Ventures, an $80 million venture capital fund, headquartered in Hong Kong. Mr. Weiss has 20 years of experience working globally in venture capital, private equity and corporate law across a diverse range of roles in Asia, including with Salomon Smith Barney, Macquarie Bank, Shinsei Bank, AXA, CLSA and Baker and McKenzie. Mr. Weiss has a BCom and LL.B from the University of NSW, is a Chartered Financial Analyst (CFA) and a graduate of Sydney College of Law. Mr. Weiss is a Member of the CFA Institute, and the Hong Kong Society of Financial Analysts and is an Associate Member of the Law Society of NSW. Mr. Weiss is also a Venture Partner for Softbank Ventures Korea, the venture capital arm of Softbank Group, based in Seoul, Korea.
Former University Professor and Associate Chair in the Agronomy Department and a Weed Management Extension Specialist at Iowa State University
Fellow of the Weed Science Society of America
Weed Science Society of America Outstanding Extension Weed Scientist
Fellow of the American Society of Agronomy
Former Weed Science Society of America Board of Directors
Emeritus Professor at the Department of Plant Sciences, Weizmann Institute of Science
Former President of the International Weed Science Society
Former President of the Israeli Weed Science society
An honorary fellow of the Weed Science Society of America
Recipient of the Israeli Prize for agriculture research